This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Merhar SL, McAllister JM, Wedig-Stevie KE, Klein AC, Meinzen-Derr J, Poindexter BB. Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome. J Perinatol. 2018;38:587–92.
Jones HE, Kaltenbach K. Neonatal abstinence syndrome. JAMA. 2012;308:762–3.
Crowe TK, Deitz JC, Bennett FC. The relationship between the Bayley Scales of Infant Development and preschool gross motor and cognitive performance. Am J Occup Ther. 1987;41:374–8.
Ziliak ST, McCloskey DN. The cult of statistical significance: how the standard error costs us jobs, justice, and llives. AnnArbor: University of Michigan Press; 2008.
Kaltenbach K, O’Grady KE, Heil SH, Salisbury AL, Coyle MG, Fischer G, et al. Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes. Drug Alcohol Depend. 2018;185:40–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Sources of Support: None
Rights and permissions
About this article
Cite this article
Jones, H.E., O’Grady, K.E. & Kaltenbach, K. Reconsidering retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome. J Perinatol 38, 1280–1281 (2018). https://doi.org/10.1038/s41372-018-0174-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-018-0174-z
This article is cited by
-
Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial
Journal of Perinatology (2023)